Cosmos Health Stock Jumps; Fueled By Posting Triple- Digit Percentage EBITDA Increase In 1H/2022 ($COSM)
Cosmos Health (NASDAQ: COSM) stock is on the move. Rightly so. After its name change from Cosmos Holdings in July, the company has been on an operational roll, posting a triple-digit percentage increase in EBITDA, strong revenue growth, a significant milestone reached by its Sky Pharm SA subsidiary, and most importantly, positioned itself and its subsidiaries to perform exceptionally well into the end of 2022 and all of 2023. Of course, keep in mind that while its name is new,


